Emergence of multiple ?-lactamases produced by Escherichia coli clinical isolates from hospitalized patient in Kerman, Iran

Davoud Kalantar; Shahla Mansouri

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

Current Issue All Issues In Press Accepted Manuscripts Search

Editors & Boards Journal Information Indexing and Listing Sources Journal Metrics Reviewer and AE Registration Form Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support

APC

Authors Guide Submit Manuscript

Emergence of multiple ?-lactamases produced by Escherichia coli clinical isolates from hospitalized patient in Kerman, Iran

Author(s):

Davoud Kalantar¹,

Shahla Mansouri^2,*,

1Department of Medical Microbiology, School of Medicine, Kerman University of Medical Sciences, Iran

2Department of Medical Microbiology, School of Medicine, Kerman University of Medical Sciences, [email protected], Iran

Jundishapur Journal of Microbiology:Vol. 3, issue 4; 137-145

Article type:Research Article

Received:Mar 01, 2010

Accepted:Jun 01, 2010

How to Cite:Davoud KalantarShahla Mansouri Emergence of multiple ?-lactamases produced by Escherichia coli clinical isolates from hospitalized patient in Kerman, Iran.Jundishapur J Microbiol.3(4):137-145.

Abstract

Introduction and objective: Escherichia coli is a major cause of urinary tract and other opportunistic infections. Emergence of antibacterial resistance and production of extended spectrum β-lactamases (ESBLs) are responsible for the frequently observed empirical therapy failures. ESBLs producing bacteria and AmpC are serious threat in treating bacterial infections. Existence of various mechanisms which create resistance to antibiotics accounts for treatment failure in infections with these bacteria. The aim of this study was to determine the presence and the prevalence of bla_CTX-M, bla_SHV, bla_TEM and bla_AmpCβ-lactamases genes in clinical isolates of E. coli in Kerman.

Materials and methods: Agar dilution method was used to determine the minimum inhibitory concentration of cefotaxime, ceftazidime and ceftizoxime in138 E. coli isolates. Resistance to imipenem, cefepime and cefoxitin was determined by disk diffusion method. Phenotypes of ESBLs and AmpC were also determined by combined disk method and non β-lactam inhibitor based method (boronic acid) respectively. PCR was used to determine bla_CTX-M, bla_SHV, bla_TEM and bla_AmpC genes in the ESBLs positive isolates.

Results: From 138 E. coli isolates 68.1% produced ESBLs by phenotypic method. Incidence rate of bla_TEM, bla_SHV and bla_CTX-Mamong ESBL producing isolates were 63.8%, 51% and 23.4%, respectively. Presence of blaTEM, blaSHV and blaCTX-M genes at the sametime was detected in10.6% of isolates. Simultaneous production of AmpC and ESBLs was observed in 6.5 % of isolates. blaAmpC gene by PCR was seen in three isolates.

Conclusion: TEM and SHV β-lactamases are the dominant β-lactamases in this area. Simultaneous production of various β-lactamases in these isolates reflects the increased ability of these isolates against antibacterial agents and; therefore, this can cause serious problems in future in the treatment of infections especially nosocomial infections of such isolates.

Keywords

Escherichia coli

Antimicrobial resistance

Extended spectrum ?-lactamase

AmpC ?-lactamase

SHV

TEM

Full Text

Full text is available in PDF

comments